Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2012 09:35 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Granted Regulatory Meeting With FDA for Femprox(R) for the Treatment of Female Sexual Arousal Disorder

SAN DIEGO, May 21, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that the United States ("U.S.") Food...
May 14, 2012 09:42 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at the 11th Annual JMP Securities Research Conference

SAN DIEGO, May 14, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that Edward Cox, Vice President Corporate Development and Investor Relations, will...
May 11, 2012 09:55 ET | Source: Seelos Therapeutics, Inc.

Health Canada Grants Apricus Biosciences Pre-NDS Meeting for MycoVa(TM) for the Treatment of Onychomycosis

SAN DIEGO, May 11, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Health Canada has granted the...
May 08, 2012 09:49 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces First Quarter 2012 Financial Results Conference Call and Provides Corporate Update

SAN DIEGO, May 8, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that management will hold a conference call to discuss its first quarter 2012...
May 07, 2012 10:10 ET | Source: Seelos Therapeutics, Inc.

Health Canada Grants Apricus Biosciences Pre-NDS Meeting for Femprox for Female Sexual Arousal Disorder

SAN DIEGO, May 7, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Health Canada has granted the...
May 04, 2012 10:05 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Poster Presentation of Femprox(R) Phase III Clinical Data at American Urological Association Annual Meeting

SAN DIEGO, May 4, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today a poster titled, "Updated analyses of...
April 26, 2012 12:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Receives Notice of Issuance for First Prevonco(TM) Patent in the United States

SAN DIEGO, April 26, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com), announced today that the Company received an Issue...
March 22, 2012 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Allowance of a NexACT(R) Technology-Based Patent in Europe for the Manufacture of DDAIP

SAN DIEGO, March 22, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com), announced today that the European Patent Office...
March 14, 2012 10:05 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences, San Diego Hospice and The Institute for Palliative Medicine Announce a Broad Clinical Research Program Using NexACT(R) Technology

SAN DIEGO, March 14, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com), San Diego Hospice (the "Hospice") and The Institute...
March 09, 2012 08:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences' CEO to Present at the 24th Annual ROTH OC Growth Stock Conference

SAN DIEGO, March 9, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that Bassam Damaj, Ph.D., Chairman, President and Chief Executive Officer, will...